About
UC-CARE has developed a patented diagnostic and treatment system designed to improve procedures for prostate diseases. The system aims to solve the problem of blind biopsies and to provide an improved system for focal treatment.
Navigo is a device that allows physicians to image, plan, place, and record prostate biopsy samples in high-resolution 3D, allowing them to more confidently sample precise areas of the prostate and record biopsy locations for future reference.
Navigo Viewer is a CD given to patients upon completion of the procedure. It enables patients and the referring physician to view the procedure summary and keep a record for future follow-ups.
SmartBx is a biopsy core preservation and management system that is designed to seamlessly integrate into the TRUS biopsy procedure and contribute to a high cancer-detection rate and improved cancer management, especially for active surveillance processes.
Navigo Fusion Studio is a software solution for fusion planning. Its automated algorithms allow radiologists and urologists to quickly prepare images to be processed by Navigo. Cases are automatically sent to the Navigo workstation, streamlining the process from planning to procedure.
Funding history · 1 round · $1.6M total
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is UC-CARE's primary focus?
- UC-CARE specializes in developing patented diagnostic and treatment systems to improve procedures for prostate diseases, specifically addressing issues like blind biopsies and providing improved focal treatment.
- When was UC-CARE founded?
- UC-CARE was founded in June 2004.
- What is the purpose of UC-CARE's Navigo device?
- Navigo is a device developed by UC-CARE that enables physicians to image, plan, place, and record prostate biopsy samples in high-resolution 3D, enhancing precision and record-keeping for future reference.
- What is SmartBx?
- SmartBx is UC-CARE's biopsy core preservation and management system designed to integrate into the TRUS biopsy procedure, aiming for a high cancer-detection rate and improved cancer management, particularly for active surveillance.
- What is Navigo Fusion Studio?
- Navigo Fusion Studio is a software solution from UC-CARE for fusion planning, featuring automated algorithms that help radiologists and urologists prepare images for processing by Navigo, streamlining the planning-to-procedure workflow.
- Where is UC-CARE's headquarters located?
- UC-CARE's headquarters is located in Yokne'am Illit, Israel.
- Has UC-CARE received any funding?
- Yes, UC-CARE received an undisclosed funding round of $1,000,000 in March 2019, with Florida Funders as an investor. For full financing history, users can refer to startupim.
- How many employees does UC-CARE currently have?
- UC-CARE currently has 17 employees.
- Does UC-CARE have a presence outside of Israel?
- Yes, UC-CARE has an office in Tampa, Florida, USA.